Kewang Luo, Ph.D. - Publications

Affiliations: 
2013 The Chinese University of Hong Kong, Hong Kong, Hong Kong 
Area:
Traditional Chinese Medicine, Cancer

15 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2017 Ko CH, Yue GG, Gao S, Luo KW, Siu WS, Shum WT, Shiu HT, Lee JK, Li G, Leung PC, Evdokiou A, Lau CB. Evaluation of the combined use of metronomic zoledronic acid and Coriolus versicolor in intratibial breast cancer mouse model. Journal of Ethnopharmacology. PMID 28412218 DOI: 10.1016/J.Jep.2017.04.007  0.332
2016 Sin SH, Xu J, Fung KY, Ng KM, Luo KQ. Evaluation of bacterial consortium construction approaches for anaerobic decolorization Journal of Environmental Chemical Engineering. 4: 1191-1198. DOI: 10.1016/j.jece.2016.01.029  0.311
2015 Luo KW, Yue GG, Ko CH, Gao S, Lee JK, Li G, Fung KP, Leung PC, Lau CB. The combined use of Camellia sinensis and metronomic zoledronate in 4T1 mouse carcinoma against tumor growth and metastasis. Oncology Reports. 34: 477-87. PMID 25998578 DOI: 10.3892/Or.2015.4001  0.532
2015 Gao S, Wan Y, Zheng G, Luo K, Kannan K, Giesy JP, Lam MH, Hu J. Organobromine compound profiling in human adipose: Assessment of sources of bromophenol. Environmental Pollution (Barking, Essex : 1987). 204: 81-9. PMID 25935608 DOI: 10.1016/J.Envpol.2015.04.015  0.436
2015 Luo KW, Ko CH, Yue GG, Gao S, Lee JK, Li G, Fung KP, Leung PC, Evdokiou A, Lau CB. The combined use of Camellia sinensis and metronomic zoledronic acid in a breast cancer-induced osteolysis mouse model. Journal of Cancer Research and Clinical Oncology. 141: 1025-36. PMID 25431338 DOI: 10.1007/S00432-014-1882-1  0.521
2014 Han XQ, Yue GL, Yue RQ, Dong CX, Chan CL, Ko CH, Cheung WS, Luo KW, Dai H, Wong CK, Leung PC, Han QB. Structure elucidation and immunomodulatory activity of a beta glucan from the fruiting bodies of Ganoderma sinense. Plos One. 9: e100380. PMID 25014571 DOI: 10.1371/Journal.Pone.0100380  0.601
2014 Zinonos I, Luo KW, Labrinidis A, Liapis V, Hay S, Panagopoulos V, Denichilo M, Ko CH, Yue GG, Lau CB, Ingman W, Ponomarev V, Atkins GJ, Findlay DM, Zannettino AC, et al. Pharmacologic inhibition of bone resorption prevents cancer-induced osteolysis but enhances soft tissue metastasis in a mouse model of osteolytic breast cancer. International Journal of Oncology. 45: 532-40. PMID 24865346 DOI: 10.3892/Ijo.2014.2468  0.376
2014 Luo KW, Yue GG, Ko CH, Lee JK, Gao S, Li LF, Li G, Fung KP, Leung PC, Lau CB. In vivo and in vitro anti-tumor and anti-metastasis effects of Coriolus versicolor aqueous extract on mouse mammary 4T1 carcinoma. Phytomedicine : International Journal of Phytotherapy and Phytopharmacology. 21: 1078-87. PMID 24856767 DOI: 10.1016/J.Phymed.2014.04.020  0.539
2014 Luo KW, Ko CH, Yue GG, Lee JK, Li KK, Lee M, Li G, Fung KP, Leung PC, Lau CB. Green tea (Camellia sinensis) extract inhibits both the metastasis and osteolytic components of mammary cancer 4T1 lesions in mice. The Journal of Nutritional Biochemistry. 25: 395-403. PMID 24561153 DOI: 10.1016/J.Jnutbio.2013.11.013  0.552
2013 Luo KW, Ko CH, Yue GG, Lee MY, Siu WS, Lee JK, Shum WT, Fung KP, Leung PC, Li G, Evdokiou A, Lau CB. Anti-tumor and anti-osteolysis effects of the metronomic use of zoledronic acid in primary and metastatic breast cancer mouse models. Cancer Letters. 339: 42-8. PMID 23896464 DOI: 10.1016/J.Canlet.2013.07.024  0.496
2012 Sun J, Yeung CA, Co NN, Tsang TY, Yau E, Luo K, Wu P, Wa JC, Fung KP, Kwok TT, Liu F. Clitocine reversal of P-glycoprotein associated multi-drug resistance through down-regulation of transcription factor NF-κB in R-HepG2 cell line. Plos One. 7: e40720. PMID 22927901 DOI: 10.1371/Journal.Pone.0040720  0.425
2011 Luo KW, Sun JG, Chan JY, Yang L, Wu SH, Fung KP, Liu FY. Anticancer effects of imperatorin isolated from Angelica dahurica: induction of apoptosis in HepG2 cells through both death-receptor- and mitochondria-mediated pathways. Chemotherapy. 57: 449-59. PMID 22189406 DOI: 10.1159/000331641  0.483
2011 Sun JG, Chen CY, Luo KW, Yeung CL, Tsang TY, Huang ZZ, Wu P, Fung KP, Kwok TT, Liu FY. 3,5-Dimethyl-H-furo[3,2-g]chromen-7-one as a potential anticancer drug by inducing p53-dependent apoptosis in human hepatoma HepG2 cells. Chemotherapy. 57: 162-72. PMID 21454974 DOI: 10.1159/000326915  0.439
2010 Han QB, Yu T, Lai F, Zhou Y, Feng C, Wang WN, Fu XH, Lau CB, Luo KQ, Xu HX, Sun HD, Fung KP, Leung PC. Quick identification of apoptosis inducer from Isodon eriocalyx by a drug discovery platform composed of analytical high-speed counter-current chromatography and the fluorescence-based caspase-3 biosensor detection. Talanta. 82: 1521-7. PMID 20801367 DOI: 10.1016/J.Talanta.2010.07.036  0.414
2009 Liu FY, Luo KW, Yu ZM, Co NN, Wu SH, Wu P, Fung KP, Kwok TT. Suillin from the mushroom Suillus placidus as potent apoptosis inducer in human hepatoma HepG2 cells. Chemico-Biological Interactions. 181: 168-74. PMID 19616521 DOI: 10.1016/J.Cbi.2009.07.008  0.494
Show low-probability matches.